Importer & Manufacturer | Source: NPPA
Published On: 28-11-2025
Enforcement Date: 23 April, 2026
NPPA has fixed retail prices of 11 formulations under Drugs (Prices Control) Order, 2013 based on the decision of 140th Authority meeting dated 27.11.2025
The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 11 drug formulations under the Drugs (Prices Control) Order, 2013. The list includes combinations containing Bisoprolol, Telmisartan, Ceftriaxone, Sulbactam, Disodium Edetate, Levocetirizine, Montelukast, Cefixime, Ofloxacin, Teneligliptin, Dapagliflozin, and Metformin. Prices are exclusive of GST and apply only to manufacturers who applied under Form I. Manufacturers must issue Form V price lists and ensure compliance with DPCO provisions.
The National Pharmaceutical Pricing Authority (NPPA) issued Order S.O. 5476(E) fixing retail prices for 11 drug formulations under paragraphs 5, 11, and 15 of the DPCO, 2013.
Key points include:
- The formulations include antihypertensive combinations of Bisoprolol and Telmisartan (2.5/40 mg and 5/40 mg)
- Other multiple injectable antibiotic formulations containing Ceftriaxone, Sulbactam, and Disodium Edetate in varying strengths
- Rest includes, Antiallergic syrup Levocetirizine + Montelukast, Antihypertensive Telmisartan + Amlodipine, Telmisartan + Hydrochlorothiazide, paediatric oral suspension Cefixime + Ofloxacin, and the antidiabetic FDC Teneligliptin + Dapagliflozin + Metformin sustained release.
- Retail prices listed are exclusive of GST.
- Manufacturers must comply with DPCO rules, issue updated price lists in Form-V via IPDMS, and ensure proper display by retailers.
- Prior price orders for these formulations stand superseded.
- Non-compliance or overcharging will result in recovery under DPCO, 2013 read with the Essential Commodities Act, 1955.
Applicable For: Importer & Manufacturer
Reference Number: CG-DL-E-28112025-268071
Notification Link